ArticleClinical ophthalmology (Auckland, N.Z.)2023

Efficacy, Safety, and Durability of Brolucizumab: An 8-Month Post-Marketing Surveillance Analysis.

Nicholas J Saba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.